Target trial emulation in oncology: current use and future directions

Your Location：

Home >

Browse articles >

Target trial emulation in oncology: current use and future directions

PERSPECTIVE | Updated：2026-08-20

Previous|Next

- Target trial emulation in oncology: current use and future directions
- Hui-Yao Huang , Le Wang , Sheng Xu , Shuo-Peng Jia , Dan-Dan Kong , Xue-Jing Zhang , Si-Qi Wang , Han-Qing He , Hao-Ran Chen , Lu-Zhu Xia , Lan-Wei Guo , Yu Tang , Ling-Bin Du , Ning Li
- Military Medical Research Vol. 13, Issue 7, Pages: 1033-1041(2026)
- Affiliations：
  Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China
  Global Statistics and Data Science, BeiGene, Shanghai 200001, China
  School of Statistics, Renmin University of China, Beijing 100872, China
  School of Public Health, Qingdao University, Qingdao 266071, Shandong, China
  Minzu University of China, Beijing 100081, China
  Department of Clinical Research Management, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China
- Author bio：
  * Ning Li ncctrials@cicams.ac.cn
- Funds：
- DOI： 10.1186/s40779-026-00685-9
  CLC：
- Accepted：28 January 2026 ，
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
Figs( 2 ) Tabs( 1 )
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

47

Views

47

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Related Articles

Unresolved questions in the application of artificial intelligence virtual cells for cancer research

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

Related Author

Pradeep K. Yadalam

Carlos M. Ardila

Carlos M. Ardila

Related Institution

Department of Basic Sciences, Biomedical Stomatology Research Group, Faculty of Dentistry, Universidad de Antioquia, U de A

Department of Basic Sciences, Saveetha Dental College, SIMATS, Saveetha University